Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Open Access
- 29 October 2021
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (6) , 335.e1-335.e17
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Daiichi-Sankyo
- Office of Naval Research
- Sanofi
- Kiadis Pharma
- National Heart, Lung, and Blood Institute (U24CA076518)
- Gilead Sciences
- National Cancer Institute
- Jazz Pharmaceuticals
- AstraZeneca
- Kyowa Kirin Pharmaceutical Development
- GlaxoSmithKline
- CareDx
- Amgen
- CSL Behring
- Bristol-Myers Squibb
- Medical College of Wisconsin
- Astellas Pharma US
- Celgene
- National Institute of Allergy and Infectious Diseases
- Karyopharm Therapeutics
- Health Resources and Services Administration (HHSH250201700006C, N00014-20-1-2705, N00014-20-1-2832)
- U.S. Public Health Service
This publication has 139 references indexed in Scilit:
- Endocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: A single tertiary care centre experienceIndian Journal of Endocrinology and Metabolism, 2013
- Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationHaematologica, 2012
- Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- Pregnancy after Hematopoietic Cell Transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)Transplantation and Cellular Therapy, 2011
- Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioningBlood, 2011
- Sexual Complaints, Pelvic Floor Symptoms, and Sexual Distress in Women over FortyThe Journal of Sexual Medicine, 2010
- Solid cancers after allogeneic hematopoietic cell transplantationBlood, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 yearsBlood, 2008
- Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patientsEuropean Journal of Cancer, 2004